Drug-eluting stents: Technical and clinical progress

M Koźlik, J Harpula, PJ Chuchra, M Nowak… - Biomimetics, 2023 - mdpi.com
Drug-eluting stents (DES) demonstrated superior efficacy when compared to bare metal
stents and plain-old balloon angioplasty and are nowadays used in almost all percutaneous …

[HTML][HTML] Twelve months clinical outcomes of ultrathin strut sirolimus-eluting stent in real-world Indian patients with coronary artery disease

P Ajmera, R Pothineni, KK Chawla… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Purpose: Although the field of interventional cardiology has witnessed extraordinary
progression, the search of an ideal coronary drug-eluting stent is still going on. Tetriflex …

[HTML][HTML] Long-Term Assessment of Thin-Strut BioMime Coronary Stent System in Real-World Population at Single-Center: A Retrospective Observational Study

GM Palleda, M Gupta, A Bansal, V Batra… - Cardiology …, 2023 - ncbi.nlm.nih.gov
Background The short-term clinical outcomes of first-generation thicker-strut durable
polymer-based drug-eluting stents (DES) have been widely examined. However, there is a …

[HTML][HTML] Evaluation of Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in an All-Comers Patient Population: 1-Year Results of the S-FLEX …

M Hudec, A Kupec, P Gazdič - Anatolian Journal of Cardiology, 2024 - ncbi.nlm.nih.gov
Background: Supraflex (Sahajanand Medical Technologies Limited, Surat, India) is a new-
generation, biodegradable polymer-coated sirolimus-eluting stent (SES) designed on an …